| Product Code: ETC7635652 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Nuclear Medicine Therapeutics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Nuclear Medicine Therapeutics Market - Industry Life Cycle |
3.4 Ireland Nuclear Medicine Therapeutics Market - Porter's Five Forces |
3.5 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Nuclear Medicine Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring nuclear medicine therapeutics |
4.2.2 Technological advancements in nuclear medicine imaging and therapy |
4.2.3 Growing awareness and acceptance of nuclear medicine therapies in Ireland |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for nuclear medicine therapeutics |
4.3.2 High cost associated with nuclear medicine procedures |
4.3.3 Limited availability of skilled professionals in the nuclear medicine field in Ireland |
5 Ireland Nuclear Medicine Therapeutics Market Trends |
6 Ireland Nuclear Medicine Therapeutics Market, By Types |
6.1 Ireland Nuclear Medicine Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, By Alpha Emitters, 2021- 2031F |
6.1.4 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, By Beta Emitters, 2021- 2031F |
6.1.5 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, By Brachy therapy, 2021- 2031F |
6.2 Ireland Nuclear Medicine Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.2.4 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, By Thyroid, 2021- 2031F |
6.2.5 Ireland Nuclear Medicine Therapeutics Market Revenues & Volume, By Other Applications, 2021- 2031F |
7 Ireland Nuclear Medicine Therapeutics Market Import-Export Trade Statistics |
7.1 Ireland Nuclear Medicine Therapeutics Market Export to Major Countries |
7.2 Ireland Nuclear Medicine Therapeutics Market Imports from Major Countries |
8 Ireland Nuclear Medicine Therapeutics Market Key Performance Indicators |
8.1 Adoption rate of nuclear medicine therapies in Ireland |
8.2 Number of research and development collaborations in the nuclear medicine sector |
8.3 Patient satisfaction levels with nuclear medicine treatments |
9 Ireland Nuclear Medicine Therapeutics Market - Opportunity Assessment |
9.1 Ireland Nuclear Medicine Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Nuclear Medicine Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Nuclear Medicine Therapeutics Market - Competitive Landscape |
10.1 Ireland Nuclear Medicine Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Ireland Nuclear Medicine Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here